D J Moliterno, E J Topol. Show Affiliations »
Abstract
Mesh： See more » AbciximabAntibodies, Monoclonal/therapeutic useCoronary Disease/drug therapyHumansImmunoglobulin Fab Fragments/therapeutic useMulticenter Studies as TopicMyocardial Infarction/drug therapyPlatelet Aggregation Inhibitors/therapeutic usePlatelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitorsRandomized Controlled Trials as TopicStentsTirofibanTyrosine/analogs & derivativesTyrosine/therapeutic use
Substances： See more » Antibodies, MonoclonalImmunoglobulin Fab FragmentsPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexTyrosineTirofibanAbciximab
Year: 2002 PMID： 12042001 DOI： 10.1053/euhj.2001.3133
Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983